StonvexLoading…
StonvexStonvexStonvexCore line items from SHAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-25 | Annual 2023 2023-12-27 | Annual 2023 2023-09-27 |
|---|---|---|---|---|
Revenue | $1.45B | $1.25B | $1.09B | $276.21M |
Operating Income | $62.51M | $3.04M | $5.92M | $5.66M |
Net Income | $45.73M | $10.21M | $20.26M | $8.14M |
EPS (Diluted) | $1.09 | $0.24 | $0.48 | $0.19 |
Total Assets | $1.90B | $1.70B | $1.61B | $1.58B |
Total Liabilities | $1.34B | $1.20B | $1.14B | $1.12B |
Cash & Equivalents | $360.12M | $320.71M | $224.65M | $190.02M |
Free Cash Flow OCF − CapEx | $56.51M | $35.66M | $-14.03M | Not available |
Shares Outstanding | 41.85M | 44.20M | 43.90M | 43.98M |